HBW Insight's David Ridley (Senior Editor, EU) and Tom Gallen (Managing Editor, EU) discuss the current situation with cannabidiol dietary supplements in Europe, covering the latest moves by the European Commission to classify CBD as a narcotic, as well as the way that individual member states Germany and France have approached the regulation of this popular ingredient.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?